Inogen Inc — Director's Dealing 2021

Feb 3, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Inogen Inc (INGN)
CIK: 0001294133
Period of Report: 2021-02-01

Reporting Person: Taylor Brenton (EVP, Engineering)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-02-01	Common Stock	M	14764	$16.62	Acquired	71356	Direct
2021-02-01	Common Stock	S	13366	$49.6575	Disposed	57990	Direct
2021-02-01	Common Stock	S	1398	$50.1145	Disposed	56592	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-02-01	Stock Option (Right to Buy	$16.62	M	14764	Disposed	2024-04-01	Common Stock (14764)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	842	Indirect

Footnotes

F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 24, 2020

F2: Represents the weighted average share price of an aggregate total of 13,366
shares sold in the price range of $49.03 to $50.03 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3: Represents the weighted average share price of an aggregate total of 1,398
shares sold in the price range of $50.04 to $50.25 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F4: Subject to the reporting person's continuing service, 1/48th of the total shares subject to the option shall vest every month after March 1, 2014.

F5: Form 4 filed on 01/11/2021 incorrectly reported the number of derivative securities beneficially owned.